Rafferty Asset Management’s Jazz Pharmaceuticals JAZZ Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $342K | Sell |
3,226
-239
| -7% | -$25.4K | ﹤0.01% | 957 |
|
2025
Q1 | $430K | Sell |
3,465
-855
| -20% | -$106K | ﹤0.01% | 901 |
|
2024
Q4 | $532K | Sell |
4,320
-1,137
| -21% | -$140K | ﹤0.01% | 896 |
|
2024
Q3 | $608K | Buy |
5,457
+326
| +6% | +$36.3K | ﹤0.01% | 892 |
|
2024
Q2 | $548K | Buy |
5,131
+815
| +19% | +$87K | ﹤0.01% | 928 |
|
2024
Q1 | $520K | Buy |
4,316
+914
| +27% | +$110K | ﹤0.01% | 966 |
|
2023
Q4 | $418K | Buy |
3,402
+705
| +26% | +$86.7K | ﹤0.01% | 1007 |
|
2023
Q3 | $349K | Buy |
2,697
+170
| +7% | +$22K | ﹤0.01% | 998 |
|
2023
Q2 | $313K | Buy |
2,527
+561
| +29% | +$69.5K | ﹤0.01% | 1035 |
|
2023
Q1 | $288K | Sell |
1,966
-222
| -10% | -$32.5K | ﹤0.01% | 1047 |
|
2022
Q4 | $349K | Buy |
2,188
+276
| +14% | +$44K | ﹤0.01% | 973 |
|
2022
Q3 | $255K | Buy |
1,912
+27
| +1% | +$3.6K | ﹤0.01% | 1042 |
|
2022
Q2 | $294K | Sell |
1,885
-1,257
| -40% | -$196K | ﹤0.01% | 921 |
|
2022
Q1 | $489K | Sell |
3,142
-4,380
| -58% | -$682K | ﹤0.01% | 1005 |
|
2021
Q4 | $958K | Buy |
7,522
+1,829
| +32% | +$233K | 0.01% | 882 |
|
2021
Q3 | $741K | Sell |
5,693
-129
| -2% | -$16.8K | 0.01% | 952 |
|
2021
Q2 | $1.03M | Buy |
5,822
+297
| +5% | +$52.7K | 0.01% | 879 |
|
2021
Q1 | $908K | Sell |
5,525
-233
| -4% | -$38.3K | 0.01% | 792 |
|
2020
Q4 | $950K | Buy |
5,758
+410
| +8% | +$67.6K | 0.01% | 515 |
|
2020
Q3 | $763K | Buy |
5,348
+2,441
| +84% | +$348K | 0.01% | 618 |
|
2020
Q2 | $321K | Buy |
+2,907
| New | +$321K | ﹤0.01% | 812 |
|
2020
Q1 | – | Sell |
-11,630
| Closed | -$1.74M | – | 704 |
|
2019
Q4 | $1.74M | Buy |
11,630
+7,682
| +195% | +$1.15M | 0.03% | 432 |
|
2019
Q3 | $506K | Buy |
3,948
+1,847
| +88% | +$237K | 0.01% | 660 |
|
2019
Q2 | $300K | Buy |
+2,101
| New | +$300K | 0.01% | 747 |
|